Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J‐BASE‐MARGIN)
- 5 May 2022
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 49 (9) , 837-844
Abstract
Basal cell carcinoma is the most common type of skin cancer, and surgical excision with clear margins is the standard of care. Surgical margins are determined based on risk factors (high or low risk) for recurrence according to the National Comprehensive Cancer Network and Japanese basal cell carcinoma guidelines. The clarity of the clinical tumor border (well-defined or poorly defined) is considered a risk factor, and significant discrepancies in the judgment of clinical tumor borders among dermato-oncologists may occur. Therefore, we analyzed the dermato-oncologists' concordance in judging the clinical tumor border of basal cell carcinoma. Forty-seven dermato-oncologists (experts: 37; young trainees: 10) participated in this study. The datasets of clinical and dermoscopic photographs of 79 Japanese cases of head and neck basal cell carcinoma were used to determine the concordance in the judgment of clinical tumor border. The probability of the border that was selected more often was used to calculate the rater agreement rate for each dataset. Correct judgment was defined as a more frequently selected border, and the concordance rate of clarity of clinical tumor border for each dermato-oncologist was calculated based on the definition of the correct judgment. A median concordance rate of 85% or higher for all dermato-oncologists was predefined as an acceptable rate for clinical use. Of the 79 datasets, rater agreement rates were 80-100%, 60-79%, and 51-59% for 55, 19, and five datasets, respectively. The median concordance rate for all dermato-oncologists was 86% (interquartile range: 82-89%). There was no significant difference in the concordance rate between the experts and the trainees (median, 87% vs. 85.5%; p = 0.58). The concordance rates of dermato-oncologists for all datasets were relatively high and acceptable for clinical use.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP21ck0106681h0001, JP21ck0106681h0002)
This publication has 13 references indexed in Scilit:
- Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012JAMA Dermatology, 2015
- Narrow‐margin excision is a safe, reliable treatment for well‐defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in JapanJournal of the European Academy of Dermatology and Venereology, 2014
- Long‐term prognosis after surgical excision of basal cell carcinoma: A single institutional study in JapanThe Journal of Dermatology, 2013
- Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical managementJournal of Plastic Surgery and Hand Surgery, 2013
- Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-upThe Lancet Oncology, 2008
- Factors Affecting the Recurrence Rate of Basal Cell CarcinomaActa Dermato-Venereologica, 2007
- Prognostic factors for a subsequent basal cell carcinoma: implications for follow-upBritish Journal of Dermatology, 2005
- Clinical and Histopathological Characteristics of Basal Cell Carcinoma in Korean PatientsThe Journal of Dermatology, 1999
- Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysisJournal of Cutaneous Pathology, 1993
- The value of typing basal cell carcinomas in predicting recurrence after surgical excisionBritish Journal of Dermatology, 1977